Pathogenesis and immune escape potential of SARS-CoV-2 variants of concern.
值得关注的 SARS-CoV-2 变体的发病机制和免疫逃逸潜力。
基本信息
- 批准号:448987
- 负责人:
- 金额:$ 18.42万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2021
- 资助国家:加拿大
- 起止时间:2021-04-01 至 2022-04-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The biology of RNA viruses, including SARS-CoV-2, is such that mutations constantly arise upon viral replication. The appearance of variants is therefore expected. The more selective pressure is put on the virus, the more frequent mutations are likely t
RNA病毒(包括SARS-CoV-2)的生物学特性是,病毒复制时会不断发生突变。 因此,预计会出现变体。 对病毒施加的选择压力越大,突变就可能越频繁。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Flamand Louis其他文献
Flamand Louis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Flamand Louis', 18)}}的其他基金
Human herpesvirus 6 and chromosomal integration
人类疱疹病毒6型和染色体整合
- 批准号:
468828 - 财政年份:2022
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
COVID-19 Variant Network - Understanding the pathogenesis of COVID-19
COVID-19 变体网络 - 了解 COVID-19 的发病机制
- 批准号:
443331 - 财政年份:2021
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
COVID-19 Variant Supplement - Understanding the pathogenesis of COVID-19
COVID-19 变异补充剂 - 了解 COVID-19 的发病机制
- 批准号:
443192 - 财政年份:2021
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
Understanding the pathogenesis of COVID-19
了解 COVID-19 的发病机制
- 批准号:
422735 - 财政年份:2020
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
COVID-19 trilogy: ARDS, inflammation and coagulopathy.
COVID-19 三部曲:ARDS、炎症和凝血病。
- 批准号:
429426 - 财政年份:2020
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
Pathogenic roles of platelets in sepsis.
血小板在脓毒症中的致病作用。
- 批准号:
395268 - 财政年份:2018
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
11th International Conference on human herpesviruses 6A, 6B and 7.
第 11 届人类疱疹病毒 6A、6B 和 7 国际会议。
- 批准号:
391960 - 财政年份:2018
- 资助金额:
$ 18.42万 - 项目类别:
Miscellaneous Programs
Human herpesvirus 6 and chromosomal integration
人类疱疹病毒6型和染色体整合
- 批准号:
370394 - 财政年份:2017
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
Increased risk of cardiovascular disease in women with inherited chromosomally-integrated human herpesvirus 6
携带遗传性染色体整合型人类疱疹病毒 6 的女性患心血管疾病的风险增加
- 批准号:
339922 - 财政年份:2015
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
Integration of human herpesvirus type 6 into chromosomes: Mechanisms and consequences.
人类疱疹病毒 6 型整合到染色体中:机制和后果。
- 批准号:
254149 - 财政年份:2012
- 资助金额:
$ 18.42万 - 项目类别:
Operating Grants
相似海外基金
Detailed Elucidation of Cancer Immune Escape Mechanisms Focusing on Regulatory T Cells in the Microenvironment of Cholangiocarcinoma
详细阐明胆管癌微环境中调节性T细胞的癌症免疫逃逸机制
- 批准号:
23K15088 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of tumor development mechanism by immune escape mechanism through metabolic reprogramming of anticancer drug-resistant cancer
通过抗癌药物耐药性癌症的代谢重编程的免疫逃逸机制阐明肿瘤发生机制
- 批准号:
23K18344 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The impact of immune escape on the epidemiology and evolutionary dynamics of the COVID-19 pandemic in Yucatan, Mexico
免疫逃逸对墨西哥尤卡坦半岛 COVID-19 大流行的流行病学和进化动态的影响
- 批准号:
10741899 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
A new concept in evolutionary epidemiology, meta-R0, on immune escape of pathogens.
进化流行病学中的一个新概念,meta-R0,关于病原体的免疫逃逸。
- 批准号:
23H02527 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Prediction of viral evolution trajectories on antigenic space using a stochastic immune escape model
使用随机免疫逃逸模型预测抗原空间上的病毒进化轨迹
- 批准号:
23K18150 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Drug discovery of next-generation circular mRNA vaccine platform targeting tumor immune escape mechanism
针对肿瘤免疫逃逸机制的下一代环状mRNA疫苗平台的药物发现
- 批准号:
22KK0288 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Novel immune-escape uricase for treatment of hyperuricemia
治疗高尿酸血症的新型免疫逃逸尿酸酶
- 批准号:
10696609 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Explore hepatitis B virus preS2 mutants as immune escape mutants
探索乙型肝炎病毒preS2突变体作为免疫逃逸突变体
- 批准号:
10572374 - 财政年份:2022
- 资助金额:
$ 18.42万 - 项目类别: